Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Meningococcal
New findings in meningococcal described from University of Oxford
August 13th, 2008
" To determine the persistence of bactericidal antibody titres following immunisation with serogroup C meningococcal glycoconjugate vaccine at age 6-15 years in,order to examine changes in persistence of antibodies with age. Observational study. Secondary and tertiary educationat institutions in the United Kingdom," scientists in Oxford, the United Kingdom report. " Healthy adolescents aged 11-20 years previously immunised between 6 and 15 years of age with one of the three serogroup C meningococcal vaccines. Serum obtained by venepuncture. Main outcome measures Percentage of participants with (rabbit complement) serum bactericidal antibody titres of at teast 1:8;...
Source: Vaccine Weekly (2008-08-13)
|
